Aldeyra Therapeutics Announces Positive Results From Phase II Clinical Trial in Subjects With Noninfectious Anterior Uveitis
May 9, 2016Company to Provide Corporate Update and First Quarter Financial Results Announcement of the Second Positive Phase II Clinical Trial of NS2 in 2016 NS2 Has Now Demonstrated Clinical Activity in the Two Major Types of Ocular Inflammation
More »
Achillion Reports First Quarter 2016 Financial Results and Provides Update on Clinical Programs
May 3, 2016Company provides update on HCV collaboration with Janssen; Phase 2b combination study evaluating doublet and triplet regimens for six and eight weeks anticipated to begin in Q3 2016
More »
Celator® Pharmaceuticals to Present Phase 3 Data at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2016Presentation Title: Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML.
More »